Trials / Completed
CompletedNCT03155295
Simulated Surgery Rehearsal (MIPN)
Patient-specific Simulated Procedure Rehearsal for Minimally Invasive Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate patient-specific surgical simulation by permitting pre-operative rehearsals, in the form of the surgeon completing a dry run of the procedure on a model constructed from the patient's radiological studies that replicates every aspect of their organs. The investigators' aim is to evaluate the effectiveness of this form of practice in optimizing intraoperative and postoperative outcomes . The investigators hope eventually to use these rehearsals as a standard study tool for surgical training.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Physical reality simulation | Using 3-D printing and polymer technology, the investigators will construct patient specific simulated hydrogel models designed from patients' imaging, incorporating the necessary anatomy, physiology and pathology specific to each patient. These models are constructed at the Laboratory for Simulation-based Translational Research at the Department of Urology. Group 1 urologists will rehearse the minimally-invasive partial nephrectomy (MIPN) surgery using these patient-specific models. |
| OTHER | Virtual reality simulation | The DaVinci surgical skills simulator system uses a virtual reality surgical simulation platform that encompasses a variety of basic exercises specifically designed to give users the opportunity to improve their proficiency with the da Vinci surgeon console controls and basic robotic surgical skills. All urologists have already completed a basic robotic skills curriculum. Group 2 urologists will complete a refresher module on the virtual reality simulator. |
Timeline
- Start date
- 2017-10-12
- Primary completion
- 2023-01-31
- Completion
- 2023-01-31
- First posted
- 2017-05-16
- Last updated
- 2023-02-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03155295. Inclusion in this directory is not an endorsement.